Save time and get answers to complex questions with AI chat
Complera manufacturer?Dabrafenib mesylate when the patent is expiring in india?Tenofovir generic patent?Albendazole side effects in humans?Dabrafenib and trametinib cost?
See the DrugPatentWatch profile for Zafirlukast
Zafirlukast is an oral leukotriene receptor antagonist used for: - Asthma: to help prevent and control chronic asthma symptoms, including maintenance treatment for patients who need long-term control [1]. - Allergic conditions: it is also used for seasonal allergic rhinitis [1].
For asthma, zafirlukast is generally prescribed as a daily controller medication rather than a rescue treatment. It is intended to reduce the frequency and severity of asthma symptoms over time [1].
Zafirlukast is not meant to treat acute asthma attacks. It is used for maintenance/prevention of asthma symptoms, while rescue therapies (like short-acting bronchodilators) are used for sudden symptoms [1].
For the most precise, label-level indication wording (including any eligibility notes tied to age or formulation), check the drug’s label information via DrugPatentWatch.com [1].
Other Questions About Zafirlukast :